Factors predictive of parametrial boost in patients with cervical cancer treated with definitive chemoradiation
Objective: The aim of this study is to identify demographic, clinical, and treatment-related characteristics associated with the prescription of parametrial boost (PMB) in cervical cancer patients undergoing definitive chemoradiation. Materials/Methods: A retrospective chart review of 132 non-metast...
Saved in:
Main Authors: | Kurl E. Jamora (Author), Johanna Patricia A. Cañal (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Parametrial Invasion in Early-Stage Cervical Cancer
by: Swita Luengyosluechakul, et al.
Published: (2020) -
FIGO IVB vaginal cancer with non-contiguous rectal metastasis treated with definitive chemoradiation: A case report
by: Marie Fort, et al.
Published: (2023) -
Effect of GSDMB polymorphism on sensitivity to chemoradiation therapy for cervical cancer
by: Ni Zhong, et al.
Published: (2021) -
Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer
by: Feiya Shi, et al.
Published: (2022) -
Treatment Response of PlatinumBased Chemoradiation on Locally Advanced Cervical Cancer
by: Oni Khonsa, et al.
Published: (2015)